Nanodiagnostics and Nanotherapeutics: Building Research Ethics & Oversight

Wolf SM. Introduction: The Challenge of Nanomedicine Human Subjects Research: Protecting Participants, Workers, Bystanders, and the Environment. Journal of Law, Medicine & Ethics  2012;40(4):712-15. Download PDF (130.53 KB)

Fatehi L, Wolf SM, McCullough J, Hall R, Lawrenz F, Kahn JP, Jones C, Campbell SA, Dresser RS, Erdman AG, Haynes CL, Hoerr RA, Hogle LF, Keane MA, Khushf G, King NMP, Kokkoli E, Marchant G, Maynard AD, Philbert M, Ramachandran G, Siegel RA, Wickline S. Recommendations for Nanomedicine Human Subjects Research Oversight: An Evolutionary Approach for an Emerging Field. Journal of Law, Medicine & Ethics 2012;40(4):716-50 . Download PDF (4.37 MB)

Fleege L, Lawrenz F. An Empirical Examination of the Current State of Publically Available Nanotechnology Guidance Materials. Journal of Law, Medicine & Ethics 2012;40(4):751-762. Download PDF (449.15 KB)

Hall RM, Sun T, Ferrari M. A Portrait of Nanomedicine and Its Bioethical Implications.  Journal of Law, Medicine & Ethics 2012;40(4):763-779. Download PDF (387.03 KB)

Khushf G, Seigel RA. What is Unique About Nanomedicine: The Significance of the Mesoscale . Journal of Law, Medicine & Ethics  2012;40(4):780-794. Download PDF (326.98 KB)

Maurer-Jones MA, Haynes CL. Toward Correlation in In Vivo and In Vitro Nanotoxicology Studies.  Journal of Law, Medicine & Ethics  2012;40(4):795-801. Download PDF (382.95 KB)

Dresser R. Building an Ethical Foundation for First-in-Human Nanotrials. Journal of Law, Medicine & Ethics 2012;40(4):802-808. Download PDF (203.81 KB)

Hogle LF. Concepts of Risk in Nanomedicine Research. Journal of Law, Medicine & Ethics  2012;40(4):809-822. Download PDF (306.63 KB)